Jingjing Chen

Affiliations: 
Dana-Farber Cancer Institute, Boston, MA, United States 
Area:
adipocyte metabolism
Google:
"Jingjing Chen"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Alajati A, D'Ambrosio M, Troiani M, et al. (2020) CDCP1 overexpression drives prostate cancer progression and can be targeted in vivo. The Journal of Clinical Investigation
Sgrignani J, Chen J, Alimonti A, et al. (2018) How phosphorylation influences E1 subunit pyruvate dehydrogenase: A computational study. Scientific Reports. 8: 14683
Chen J, Guccini I, Di Mitri D, et al. (2018) Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nature Genetics
Chen J, Guccini I, Mitri DD, et al. (2018) Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nature Genetics
Revandkar A, Perciato ML, Toso A, et al. (2016) Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence. Nature Communications. 7: 13719
Matic I, Revandkar A, Chen J, et al. (2016) Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay. Aging
Kalathur M, Toso A, Chen J, et al. (2015) A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours. Nature Communications. 6: 7227
See more...